{"id":"https://openalex.org/W4409633147","doi":"https://doi.org/10.1158/1538-7445.am2025-4378","title":"Abstract 4378: BBO-11818, an orally bioavailable, highly potent and non-covalent pan-KRAS inhibitor demonstrates robust anti-tumor activity in KRAS-mutant preclinical models","display_name":"Abstract 4378: BBO-11818, an orally bioavailable, highly potent and non-covalent pan-KRAS inhibitor demonstrates robust anti-tumor activity in KRAS-mutant preclinical models","publication_year":2025,"publication_date":"2025-04-21","ids":{"openalex":"https://openalex.org/W4409633147","doi":"https://doi.org/10.1158/1538-7445.am2025-4378"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2025-4378","doi":"https://doi.org/10.1158/1538-7445.am2025-4378","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2025-4378","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5000809061","display_name":"Carlos E. Stahlhut","orcid":"https://orcid.org/0000-0002-8472-7156","observed_orcids":["https://orcid.org/0000-0002-8472-7156"]},"institutions":[{"id":"https://openalex.org/I4405263923","display_name":"BridgeBio Oncology Therapeutics (United States)","ror":"https://ror.org/00e3m0q94","country_code":"US","type":"company","lineage":["https://openalex.org/I4405263923"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Carlos Ernesto Stahlhut Espinosa","raw_affiliation_strings":["1BridgeBio Oncology Threapeutics, South San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1BridgeBio Oncology Threapeutics, South San Francisco, CA;","institution_ids":["https://openalex.org/I4405263923"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051980304","display_name":"Kanchan Singh","orcid":"https://orcid.org/0000-0002-7140-434X","observed_orcids":["https://orcid.org/0000-0002-7140-434X"]},"institutions":[{"id":"https://openalex.org/I4405263923","display_name":"BridgeBio Oncology Therapeutics (United States)","ror":"https://ror.org/00e3m0q94","country_code":"US","type":"company","lineage":["https://openalex.org/I4405263923"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kanchan Singh","raw_affiliation_strings":["1BridgeBio Oncology Threapeutics, South San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1BridgeBio Oncology Threapeutics, South San Francisco, CA;","institution_ids":["https://openalex.org/I4405263923"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061885987","display_name":"Zuhui Zhang","orcid":"https://orcid.org/0009-0002-2994-2352","observed_orcids":["https://orcid.org/0009-0002-2994-2352"]},"institutions":[{"id":"https://openalex.org/I4405263923","display_name":"BridgeBio Oncology Therapeutics (United States)","ror":"https://ror.org/00e3m0q94","country_code":"US","type":"company","lineage":["https://openalex.org/I4405263923"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Zuhui Zhang","raw_affiliation_strings":["1BridgeBio Oncology Threapeutics, South San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1BridgeBio Oncology Threapeutics, South San Francisco, CA;","institution_ids":["https://openalex.org/I4405263923"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029948101","display_name":"Kyle A. Sullivan","orcid":"https://orcid.org/0009-0002-7860-7948","observed_orcids":["https://orcid.org/0009-0002-7860-7948","https://orcid.org/0000-0002-4621-5598"]},"institutions":[{"id":"https://openalex.org/I4405263923","display_name":"BridgeBio Oncology Therapeutics (United States)","ror":"https://ror.org/00e3m0q94","country_code":"US","type":"company","lineage":["https://openalex.org/I4405263923"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kyle Sullivan","raw_affiliation_strings":["1BridgeBio Oncology Threapeutics, South San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1BridgeBio Oncology Threapeutics, South San Francisco, CA;","institution_ids":["https://openalex.org/I4405263923"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072954821","display_name":"Nadege Gitego","orcid":"https://orcid.org/0009-0006-1024-8618","observed_orcids":["https://orcid.org/0009-0006-1024-8618"]},"institutions":[{"id":"https://openalex.org/I4405263923","display_name":"BridgeBio Oncology Therapeutics (United States)","ror":"https://ror.org/00e3m0q94","country_code":"US","type":"company","lineage":["https://openalex.org/I4405263923"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nadege Gitego","raw_affiliation_strings":["1BridgeBio Oncology Threapeutics, South San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1BridgeBio Oncology Threapeutics, South San Francisco, CA;","institution_ids":["https://openalex.org/I4405263923"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016497939","display_name":"Megan Rigby","orcid":"https://orcid.org/0000-0002-4438-9797","observed_orcids":["https://orcid.org/0000-0002-4438-9797","https://orcid.org/0000-0002-6268-0414"]},"institutions":[{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Megan Rigby","raw_affiliation_strings":["2Frederick National Laboratory for Cancer Research, Frederick, MD;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Frederick National Laboratory for Cancer Research, Frederick, MD;","institution_ids":["https://openalex.org/I4210130649"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021648640","display_name":"Roger Ma","orcid":"https://orcid.org/0000-0003-2251-2640","observed_orcids":["https://orcid.org/0000-0003-2251-2640"]},"institutions":[{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Roger Ma","raw_affiliation_strings":["2Frederick National Laboratory for Cancer Research, Frederick, MD;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Frederick National Laboratory for Cancer Research, Frederick, MD;","institution_ids":["https://openalex.org/I4210130649"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009326935","display_name":"Patrick Alexander","orcid":"https://orcid.org/0000-0001-8601-1760","observed_orcids":["https://orcid.org/0000-0001-8601-1760"]},"institutions":[{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Patrick Alexander","raw_affiliation_strings":["2Frederick National Laboratory for Cancer Research, Frederick, MD;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Frederick National Laboratory for Cancer Research, Frederick, MD;","institution_ids":["https://openalex.org/I4210130649"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5095089852","display_name":"Saman Setoodeh","orcid":"https://orcid.org/0009-0008-5840-5525","observed_orcids":["https://orcid.org/0009-0008-5840-5525"]},"institutions":[{"id":"https://openalex.org/I4405263923","display_name":"BridgeBio Oncology Therapeutics (United States)","ror":"https://ror.org/00e3m0q94","country_code":"US","type":"company","lineage":["https://openalex.org/I4405263923"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Saman Setoodeh","raw_affiliation_strings":["1BridgeBio Oncology Threapeutics, South San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1BridgeBio Oncology Threapeutics, South San Francisco, CA;","institution_ids":["https://openalex.org/I4405263923"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101057416","display_name":"Shu Jin","orcid":"https://orcid.org/0009-0000-8974-3940","observed_orcids":["https://orcid.org/0009-0000-8974-3940"]},"institutions":[{"id":"https://openalex.org/I4405263923","display_name":"BridgeBio Oncology Therapeutics (United States)","ror":"https://ror.org/00e3m0q94","country_code":"US","type":"company","lineage":["https://openalex.org/I4405263923"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jin Shu","raw_affiliation_strings":["1BridgeBio Oncology Threapeutics, South San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1BridgeBio Oncology Threapeutics, South San Francisco, CA;","institution_ids":["https://openalex.org/I4405263923"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101945774","display_name":"Kenneth Lin","orcid":"https://orcid.org/0000-0001-9643-5858","observed_orcids":["https://orcid.org/0000-0001-9643-5858"]},"institutions":[{"id":"https://openalex.org/I4405263923","display_name":"BridgeBio Oncology Therapeutics (United States)","ror":"https://ror.org/00e3m0q94","country_code":"US","type":"company","lineage":["https://openalex.org/I4405263923"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ken Lin","raw_affiliation_strings":["1BridgeBio Oncology Threapeutics, South San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1BridgeBio Oncology Threapeutics, South San Francisco, CA;","institution_ids":["https://openalex.org/I4405263923"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061895849","display_name":"Dana Rabara","orcid":"https://orcid.org/0009-0008-7411-3418","observed_orcids":["https://orcid.org/0009-0008-7411-3418"]},"institutions":[{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dana Rabara","raw_affiliation_strings":["2Frederick National Laboratory for Cancer Research, Frederick, MD;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Frederick National Laboratory for Cancer Research, Frederick, MD;","institution_ids":["https://openalex.org/I4210130649"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071656740","display_name":"Erik K. Larsen","orcid":"https://orcid.org/0000-0002-7553-212X","observed_orcids":["https://orcid.org/0000-0002-7553-212X"]},"institutions":[{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Erik Larsen","raw_affiliation_strings":["2Frederick National Laboratory for Cancer Research, Frederick, MD;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Frederick National Laboratory for Cancer Research, Frederick, MD;","institution_ids":["https://openalex.org/I4210130649"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100621624","display_name":"Alok Kumar Sharma","orcid":"https://orcid.org/0000-0001-8011-1074","observed_orcids":["https://orcid.org/0000-0001-8011-1074"]},"institutions":[{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alok Sharma","raw_affiliation_strings":["2Frederick National Laboratory for Cancer Research, Frederick, MD;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Frederick National Laboratory for Cancer Research, Frederick, MD;","institution_ids":["https://openalex.org/I4210130649"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091297835","display_name":"Albert H. Chan","orcid":"https://orcid.org/0000-0001-5809-8483","observed_orcids":["https://orcid.org/0000-0001-5809-8483"]},"institutions":[{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Albert Chan","raw_affiliation_strings":["2Frederick National Laboratory for Cancer Research, Frederick, MD;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Frederick National Laboratory for Cancer Research, Frederick, MD;","institution_ids":["https://openalex.org/I4210130649"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111867939","display_name":"Bryan D. Smith","orcid":"https://orcid.org/0009-0002-7666-7517","observed_orcids":["https://orcid.org/0009-0002-7666-7517"]},"institutions":[{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brian P. Smith","raw_affiliation_strings":["2Frederick National Laboratory for Cancer Research, Frederick, MD;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Frederick National Laboratory for Cancer Research, Frederick, MD;","institution_ids":["https://openalex.org/I4210130649"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070024846","display_name":"Andrew G. Stephen","orcid":"https://orcid.org/0000-0002-8259-621X","observed_orcids":["https://orcid.org/0000-0002-8259-621X"]},"institutions":[{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrew Stephen","raw_affiliation_strings":["2Frederick National Laboratory for Cancer Research, Frederick, MD;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Frederick National Laboratory for Cancer Research, Frederick, MD;","institution_ids":["https://openalex.org/I4210130649"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5115593943","display_name":"Yue Yang","orcid":"https://orcid.org/0000-0002-8270-9464","observed_orcids":["https://orcid.org/0000-0002-8270-9464"]},"institutions":[{"id":"https://openalex.org/I4405263923","display_name":"BridgeBio Oncology Therapeutics (United States)","ror":"https://ror.org/00e3m0q94","country_code":"US","type":"company","lineage":["https://openalex.org/I4405263923"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yue Yang","raw_affiliation_strings":["1BridgeBio Oncology Threapeutics, South San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1BridgeBio Oncology Threapeutics, South San Francisco, CA;","institution_ids":["https://openalex.org/I4405263923"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Jun Pei","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1282311441","display_name":"Lawrence Livermore National Laboratory","ror":"https://ror.org/041nk4h53","country_code":"US","type":"facility","lineage":["https://openalex.org/I1282311441","https://openalex.org/I1330989302","https://openalex.org/I198811213","https://openalex.org/I4210138311"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jun Pei","raw_affiliation_strings":["3Lawrence Livermore National Laboratory, Livermore, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Lawrence Livermore National Laboratory, Livermore, CA","institution_ids":["https://openalex.org/I1282311441"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020056606","display_name":"Felice C. Lightstone","orcid":"https://orcid.org/0000-0003-1465-426X","observed_orcids":["https://orcid.org/0000-0003-1465-426X"]},"institutions":[{"id":"https://openalex.org/I1282311441","display_name":"Lawrence Livermore National Laboratory","ror":"https://ror.org/041nk4h53","country_code":"US","type":"facility","lineage":["https://openalex.org/I1282311441","https://openalex.org/I1330989302","https://openalex.org/I198811213","https://openalex.org/I4210138311"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Felice C. Lightstone","raw_affiliation_strings":["3Lawrence Livermore National Laboratory, Livermore, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Lawrence Livermore National Laboratory, Livermore, CA","institution_ids":["https://openalex.org/I1282311441"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030623342","display_name":"Dhirendra K. Simanshu","orcid":"https://orcid.org/0000-0002-9717-4618","observed_orcids":["https://orcid.org/0000-0002-9717-4618"]},"institutions":[{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dhirendra Simanshu","raw_affiliation_strings":["2Frederick National Laboratory for Cancer Research, Frederick, MD;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Frederick National Laboratory for Cancer Research, Frederick, MD;","institution_ids":["https://openalex.org/I4210130649"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101751375","display_name":"Rui Xu","orcid":"https://orcid.org/0009-0009-8393-4135","observed_orcids":["https://orcid.org/0009-0009-8393-4135"]},"institutions":[{"id":"https://openalex.org/I4405263923","display_name":"BridgeBio Oncology Therapeutics (United States)","ror":"https://ror.org/00e3m0q94","country_code":"US","type":"company","lineage":["https://openalex.org/I4405263923"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rui Xu","raw_affiliation_strings":["1BridgeBio Oncology Threapeutics, South San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1BridgeBio Oncology Threapeutics, South San Francisco, CA;","institution_ids":["https://openalex.org/I4405263923"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079873570","display_name":"Chunmei Ji","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405263923","display_name":"BridgeBio Oncology Therapeutics (United States)","ror":"https://ror.org/00e3m0q94","country_code":"US","type":"company","lineage":["https://openalex.org/I4405263923"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Chunmei Ji","raw_affiliation_strings":["1BridgeBio Oncology Threapeutics, South San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1BridgeBio Oncology Threapeutics, South San Francisco, CA;","institution_ids":["https://openalex.org/I4405263923"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026746688","display_name":"Keshi Wang","orcid":"https://orcid.org/0009-0000-7576-6447","observed_orcids":["https://orcid.org/0009-0000-7576-6447"]},"institutions":[{"id":"https://openalex.org/I4405263923","display_name":"BridgeBio Oncology Therapeutics (United States)","ror":"https://ror.org/00e3m0q94","country_code":"US","type":"company","lineage":["https://openalex.org/I4405263923"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Keshi Wang","raw_affiliation_strings":["1BridgeBio Oncology Threapeutics, South San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1BridgeBio Oncology Threapeutics, South San Francisco, CA;","institution_ids":["https://openalex.org/I4405263923"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100782629","display_name":"Bin Wang","orcid":"https://orcid.org/0000-0003-1293-5041","observed_orcids":["https://orcid.org/0000-0003-1293-5041"]},"institutions":[{"id":"https://openalex.org/I4405263923","display_name":"BridgeBio Oncology Therapeutics (United States)","ror":"https://ror.org/00e3m0q94","country_code":"US","type":"company","lineage":["https://openalex.org/I4405263923"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bin Wang","raw_affiliation_strings":["1BridgeBio Oncology Threapeutics, South San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1BridgeBio Oncology Threapeutics, South San Francisco, CA;","institution_ids":["https://openalex.org/I4405263923"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072818782","display_name":"Kerstin W. Sinkevicius","orcid":"https://orcid.org/0000-0002-4000-6277","observed_orcids":["https://orcid.org/0000-0002-4000-6277"]},"institutions":[{"id":"https://openalex.org/I4405263923","display_name":"BridgeBio Oncology Therapeutics (United States)","ror":"https://ror.org/00e3m0q94","country_code":"US","type":"company","lineage":["https://openalex.org/I4405263923"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kerstin Sinkevicius","raw_affiliation_strings":["1BridgeBio Oncology Threapeutics, South San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1BridgeBio Oncology Threapeutics, South San Francisco, CA;","institution_ids":["https://openalex.org/I4405263923"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046377031","display_name":"Dwight V. Nissley","orcid":"https://orcid.org/0000-0001-7523-116X","observed_orcids":["https://orcid.org/0000-0001-7523-116X"]},"institutions":[{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dwight V. Nissley","raw_affiliation_strings":["2Frederick National Laboratory for Cancer Research, Frederick, MD;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Frederick National Laboratory for Cancer Research, Frederick, MD;","institution_ids":["https://openalex.org/I4210130649"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114048089","display_name":"Eli M. Wallace","orcid":"https://orcid.org/0009-0006-1692-7160","observed_orcids":["https://orcid.org/0009-0006-1692-7160"]},"institutions":[{"id":"https://openalex.org/I4405263923","display_name":"BridgeBio Oncology Therapeutics (United States)","ror":"https://ror.org/00e3m0q94","country_code":"US","type":"company","lineage":["https://openalex.org/I4405263923"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eli Wallace","raw_affiliation_strings":["1BridgeBio Oncology Threapeutics, South San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1BridgeBio Oncology Threapeutics, South San Francisco, CA;","institution_ids":["https://openalex.org/I4405263923"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082685256","display_name":"Frank P. McCormick","orcid":"https://orcid.org/0000-0002-6619-7120","observed_orcids":["https://orcid.org/0000-0002-6619-7120"]},"institutions":[{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Frank McCormick","raw_affiliation_strings":["2Frederick National Laboratory for Cancer Research, Frederick, MD;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Frederick National Laboratory for Cancer Research, Frederick, MD;","institution_ids":["https://openalex.org/I4210130649"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000314948","display_name":"Anna E. Maciag","orcid":"https://orcid.org/0000-0001-6562-5640","observed_orcids":["https://orcid.org/0000-0001-6562-5640"]},"institutions":[{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anna E. Maciag","raw_affiliation_strings":["2Frederick National Laboratory for Cancer Research, Frederick, MD;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Frederick National Laboratory for Cancer Research, Frederick, MD;","institution_ids":["https://openalex.org/I4210130649"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5019770407","display_name":"Pedro J. Beltran","orcid":"https://orcid.org/0000-0002-4103-6494","observed_orcids":["https://orcid.org/0000-0002-4103-6494"]},"institutions":[{"id":"https://openalex.org/I4405263923","display_name":"BridgeBio Oncology Therapeutics (United States)","ror":"https://ror.org/00e3m0q94","country_code":"US","type":"company","lineage":["https://openalex.org/I4405263923"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pedro J. Beltran","raw_affiliation_strings":["1BridgeBio Oncology Threapeutics, South San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1BridgeBio Oncology Threapeutics, South San Francisco, CA;","institution_ids":["https://openalex.org/I4405263923"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":8,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"85","issue":"8_Supplement_1","first_page":"4378","last_page":"4378"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10169","display_name":"Protein Kinase Regulation and GTPase Signaling","score":0.9721999764442444,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10169","display_name":"Protein Kinase Regulation and GTPase Signaling","score":0.9721999764442444,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.01269999984651804,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12104","display_name":"Protein Tyrosine Phosphatases","score":0.004900000058114529,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pan-kras-inhibitors","display_name":"pan-KRAS inhibitors","score":0.9430000185966492},{"id":"https://openalex.org/keywords/kras-g12d","display_name":"KRAS G12D","score":0.9070000052452087},{"id":"https://openalex.org/keywords/kras-g12v","display_name":"KRAS G12V","score":1.0},{"id":"https://openalex.org/keywords/kras-mutant-cancer","display_name":"KRAS-mutant cancer","score":0.7630000114440918},{"id":"https://openalex.org/keywords/mapk-signaling","display_name":"MAPK signaling","score":0.7160000205039978},{"id":"https://openalex.org/keywords/raf-1","display_name":"Raf-1","score":0.6420000195503235},{"id":"https://openalex.org/keywords/pancreatic-ductal-adenocarcinoma","display_name":"pancreatic ductal adenocarcinoma","score":0.8679999709129333},{"id":"https://openalex.org/keywords/colorectal-cancer","display_name":"colorectal cancer","score":0.878000020980835},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.9929999709129333},{"id":"https://openalex.org/keywords/oral-bioavailability","display_name":"oral bioavailability","score":0.6840000152587891}],"concepts":[{"id":"https://openalex.org/C2781187634","wikidata":"https://www.wikidata.org/wiki/Q20969980","display_name":"KRAS","level":4,"score":0.8635522127151489},{"id":"https://openalex.org/C181389837","wikidata":"https://www.wikidata.org/wiki/Q461809","display_name":"Bioavailability","level":2,"score":0.6539932489395142},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6177279353141785},{"id":"https://openalex.org/C3017990168","wikidata":"https://www.wikidata.org/wiki/Q285166","display_name":"Orally active","level":3,"score":0.4302319884300232},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.42950135469436646},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.41516605019569397},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.40497732162475586},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3102056384086609},{"id":"https://openalex.org/C2777056448","wikidata":"https://www.wikidata.org/wiki/Q285166","display_name":"Oral administration","level":2,"score":0.19066381454467773},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.18840941786766052},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.1736924648284912}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2025-4378","doi":"https://doi.org/10.1158/1538-7445.am2025-4378","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2025-4378","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7148778456","https://openalex.org/W4415456661","https://openalex.org/W7134037560","https://openalex.org/W4389239767","https://openalex.org/W4409820714","https://openalex.org/W7148765063","https://openalex.org/W7148736477","https://openalex.org/W4365511916","https://openalex.org/W4409629785","https://openalex.org/W4409625600"],"abstract_inverted_index":{"Abstract":[0],"KRAS":[1,33,82,100,125,140,164,320],"is":[2,165,292],"the":[3,115,121,144,285,308,421],"most":[4],"commonly":[5],"mutated":[6],"oncogene,":[7],"altered":[8],"in":[9,36,88,106,114,143,187,197,205,225,263,280,284,413],"approximately":[10],"15%":[11],"of":[12,17,123,146,151,161,190,203,228,250,305,319,420],"human":[13],"cancers.":[14],"While":[15],"inhibitors":[16],"KRASG12C":[18],"have":[19,67],"shown":[20],"promising":[21],"clinical":[22,64],"efficacy,":[23],"there":[24],"are":[25],"currently":[26,323],"no":[27],"approved":[28],"targeted":[29,325],"therapies":[30],"against":[31,80,172,299],"other":[32],"variants,":[34],"resulting":[35,142,279],"a":[37,70,242,273,293,316],"significant":[38],"underserved":[39],"patient":[40],"population":[41],"across":[42],"several":[43,138],"major":[44],"cancer":[45,52,58],"types,":[46],"including":[47,84,220],"pancreatic":[48],"carcinoma":[49],"(PDAC),":[50],"colorectal":[51,235],"(CRC),":[53],"and":[54,86,93,104,109,149,174,183,200,207,234,302,405],"non-small":[55,231],"cell":[56,152,176,232],"lung":[57],"(NSCLC).":[59],"To":[60],"address":[61],"this":[62],"unmet":[63],"need,":[65],"we":[66],"developed":[68],"BBO-11818:":[69],"potent,":[71],"selective,":[72],"orally":[73,401],"bioavailable":[74],"non-covalent":[75,406],"pan-KRAS":[76,295,407],"inhibitor":[77,296,408],"with":[78,101,126,154,239,276,297],"activity":[79,298,412],"multiple":[81],"mutants,":[83,141],"KRASG12D":[85,206,266],"KRASG12V,":[87],"both":[89,300],"their":[90],"inactive":[91,110,116],"GDP-bound":[92],"active":[94,108],"GTP-bound":[95,124],"states.":[96],"BBO-11818":[97,135,162,178,214,258,270,291],"binds":[98],"mutant":[99,321],"high":[102],"affinity":[103],"selectivity":[105,160],"its":[107,127,168],"conformations,":[111],"locking":[112],"it":[113],"State":[117],"1":[118,431],"to":[119,310],"disrupt":[120],"association":[122],"key":[128],"effector":[129],"RAF1.":[130],"Cell-based":[131],"assays":[132],"confirm":[133],"that":[134,246],"potently":[136],"inhibits":[137],"driver":[139],"suppression":[145],"MAPK":[147],"signaling":[148],"inhibition":[150,202],"proliferation":[153],"low":[155],"nanomolar":[156],"EC50":[157],"values.":[158],"The":[159],"for":[163,424],"demonstrated":[166],"by":[167],">1000-fold":[169],"lower":[170],"potency":[171],"NRAS-":[173],"BRAF-mutant":[175],"lines.":[177],"exhibits":[179],"favorable":[180],"pharmacokinetic":[181],"(PK)":[182],"pharmacodynamic":[184],"(PD)":[185],"properties":[186],"mouse":[188,289],"models":[189,227,264,416],"cancer.":[191,236],"Single":[192],"dose,":[193],"oral":[194],"administration":[195],"results":[196],"strong":[198,217],"dose-":[199],"time-dependent":[201],"pERK":[204],"KRASG12V":[208,268],"cell-derived":[209],"xenograft":[210],"(CDX)":[211],"models.":[212],"Importantly,":[213],"monotherapy":[215,313],"induces":[216],"anti-tumor":[218,411],"responses,":[219],"regression":[221],"at":[222],"well-tolerated":[223],"doses":[224],"CDX":[226],"KRAS-mutant":[229,414],"pancreatic,":[230],"lung,":[233],"In":[237],"combination":[238,274],"either":[240],"BBO-10203,":[241],"selective":[243],"RAS:PI3K\u03b1":[244],"breaker":[245],"blocks":[247],"RAS-mediated":[248],"activation":[249],"AKT;":[251],"or":[252,267,314],"cetuximab,":[253],"an":[254,400],"anti-EGFR":[255],"monoclonal":[256],"antibody,":[257],"shows":[259,272],"significantly":[260],"enhanced":[261],"efficacy":[262],"harboring":[265],"mutations.":[269],"also":[271],"benefit":[275],"anti-PD-1":[277],"treatment,":[278],"complete":[281],"tumor":[282,288],"regressions":[283],"CT-26":[286],"syngeneic":[287],"model.":[290],"potent":[294,404],"GTP":[301],"GDP":[303],"forms":[304],"KRAS,":[306],"presenting":[307],"opportunity":[309],"address,":[311],"as":[312],"combination,":[315],"large":[317],"fraction":[318],"tumors":[322],"lacking":[324],"therapeutic":[326],"options.":[327],"Citation":[328],"Format:":[329],"Carlos":[330],"Ernesto":[331],"Stahlhut":[332],"Espinosa,":[333],"Kanchan":[334],"Singh,":[335],"Zuhui":[336],"Zhang,":[337],"Kyle":[338],"Sullivan,":[339],"Nadege":[340],"Gitego,":[341],"Megan":[342],"Rigby,":[343],"Roger":[344],"Ma,":[345],"Patrick":[346],"Alexander,":[347],"Saman":[348],"Setoodeh,":[349],"Jin":[350],"Shu,":[351],"Ken":[352],"Lin,":[353],"Dana":[354],"Rabara,":[355],"Erik":[356],"Larsen,":[357],"Alok":[358],"Sharma,":[359],"Albert":[360],"Chan,":[361],"Brian":[362],"P.":[363],"Smith,":[364],"Andrew":[365],"Stephen,":[366],"Yue":[367],"Yang,":[368],"Jun":[369],"Pei,":[370],"Felice":[371],"C.":[372],"Lightstone,":[373],"Dhirendra":[374],"Simanshu,":[375],"Rui":[376],"Xu,":[377],"Chunmei":[378],"Ji,":[379],"Keshi":[380],"Wang,":[381,383],"Bin":[382],"Kerstin":[384],"Sinkevicius,":[385],"Dwight":[386],"V.":[387],"Nissley,":[388],"Eli":[389],"Wallace,":[390],"Frank":[391],"McCormick,":[392],"Anna":[393],"E.":[394],"Maciag,":[395],"Pedro":[396],"J.":[397],"Beltran.":[398],"BBO-11818,":[399],"bioavailable,":[402],"highly":[403],"demonstrates":[409],"robust":[410],"preclinical":[415],"[abstract].":[417],"In:":[418],"Proceedings":[419],"American":[422],"Association":[423],"Cancer":[425,442],"Research":[426],"Annual":[427],"Meeting":[428],"2025;":[429],"Part":[430],"(Regular":[432],"Abstracts);":[433],"2025":[434],"Apr":[435],"25-30;":[436],"Chicago,":[437],"IL.":[438],"Philadelphia":[439],"(PA):":[440],"AACR;":[441],"Res":[443],"2025;85(8_Suppl_1):Abstract":[444],"nr":[445],"4378.":[446]},"counts_by_year":[{"year":2026,"cited_by_count":6},{"year":2025,"cited_by_count":2}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2025-04-21T00:00:00"}